Progress In Personalized Medicine Is Slower Than Some Had Expected, Partly Because Of The Science And Partly Because Of Insufficient Economic Incentives, Particularly For Investing In Molecular Diagnostics (MDX)
May 1, 2014, 00:00
10.1016/j.jval.2014.03.083
https://www.valueinhealthjournal.com/article/S1098-3015(14)00134-X/fulltext
Title :
Progress In Personalized Medicine Is Slower Than Some Had Expected, Partly Because Of The Science And Partly Because Of Insufficient Economic Incentives, Particularly For Investing In Molecular Diagnostics (MDX)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00134-X&doi=10.1016/j.jval.2014.03.083
First page :
A13
Section Title :
Health Care Use and Policy Studies
Open access? :
No
Section Order :
188